Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: Trial of Acebilustat for the Treatment of Upper Arm Lymphedema [Phase 2]

View source ↗

Summary

This document updates on a Phase 2 trial of Acebilustat for lymphedema of the upper arm, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acebilustat

Snippet

Sponsor: Stanford University | Conditions: Lymphedema of Upper Arm | Phase 2 | Status: ACTIVE_NOT_RECRUITING